IO Biotech, Inc.
IOBT
$1.72
$0.010.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.22M | -22.42M | -31.33M | -24.02M | -20.69M |
| Total Depreciation and Amortization | 234.00K | 227.00K | 219.00K | 205.00K | 214.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.82M | 1.67M | 6.30M | 52.00K | 1.73M |
| Change in Net Operating Assets | 1.34M | -2.55M | 5.19M | 2.95M | 1.76M |
| Cash from Operations | -19.82M | -23.07M | -19.63M | -20.81M | -16.98M |
| Capital Expenditure | -26.00K | -28.00K | -11.00K | -10.00K | -12.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -26.00K | -28.00K | -11.00K | -10.00K | -12.00K |
| Total Debt Issued | 11.72M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -233.00K | -- | -- | -- | -- |
| Cash from Financing | 11.49M | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -594.00K | 154.00K | -518.00K | 256.00K | -241.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.96M | -22.95M | -20.15M | -20.56M | -17.24M |